How historic analogs can help your team decide whether to pursue or license a product.
When early identification of payer priorities can lead to beneficial adjustments to your product’s value proposition.
What kind of data helps you anticipate (and circumvent) launch disadvantages.
As market access challenges grow, pharma companies are beginning their pre-launch planning much earlier in the product lifecycle. But what can pharma companies hope to learn about the competitive landscape so far in advance? This webinar details how and why manufacturers benefit from early market research, using client use cases to show how planning for potential access scenarios leads to greater utilization at launch.